← Back
$EBS All transactions

Emergent BioSolutions Inc.

A

$ Value

$0

Shares

34,403

Price

$0

Filed

May 2

Insider

Name

White Marvin L

Title

CIK

0001493324

Roles

Director

Transaction Details

Transaction Date

2025-04-30

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

88,495

Footnotes

Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the "Company") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. | Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price. | The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant.

Filing Info

Accession No.

0001367644-25-000110

Form Type

4

Issuer CIK

0001367644

White Marvin L's History

Date Ticker Type Value
2025-08-06 APVO A $0
2025-07-17 APVO M
2025-07-17 APVO M $0
2025-04-30 EBS A $0
2025-04-30 EBS A $0

Other Insiders at EBS (90d)

Insider Bought Sold Last
FOWLER JOHN D JR 2026-03-03
LINDAHL RICHARD S
EVP, Chief Financial Officer
2026-03-05
PAPA JOSEPH C
President and CEO
2026-03-05
Glessner Coleen
EVP, Quality & Ethics, and CPL
2026-03-05
Williams Paul Anthony
SVP, Products Business
$34K 2026-04-01
Hartzel William
SVP, Bioservices
2026-03-05
Perl Jessica
SVP, General Counsel, Corp Sec
2026-03-05
Lowry Simon C
SVP, R&D, CMO
2026-03-05